• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

SGLT2 Inhibitors in Heart Failure: Targeted Metabolomics and Energetic Metabolism.

作者信息

Santos-Gallego Carlos G, Mayr Manuel, Badimon Juan

机构信息

AtheroThrombosis Research Unit, Mount Sinai Hospital, New York (C.G.S.-G., J.B.).

British Heart Foundation Centre, King's College London, UK (M.M.).

出版信息

Circulation. 2022 Sep 13;146(11):819-821. doi: 10.1161/CIRCULATIONAHA.122.060805. Epub 2022 Sep 12.

DOI:10.1161/CIRCULATIONAHA.122.060805
PMID:36095062
Abstract
摘要

相似文献

1
SGLT2 Inhibitors in Heart Failure: Targeted Metabolomics and Energetic Metabolism.心力衰竭中的钠-葡萄糖协同转运蛋白2抑制剂：靶向代谢组学与能量代谢
Circulation. 2022 Sep 13;146(11):819-821. doi: 10.1161/CIRCULATIONAHA.122.060805. Epub 2022 Sep 12.
2
Proving SGLT2 Inhibitor-Mediated Improvement in Cardiomyocyte Energetics: Beyond a Reasonable Doubt?证明SGLT2抑制剂介导的心肌细胞能量代谢改善：毫无疑问？
Circ Heart Fail. 2024 Jun;17(6):e011646. doi: 10.1161/CIRCHEARTFAILURE.124.011646. Epub 2024 Jun 7.
3
Treatments for skeletal muscle abnormalities in heart failure: sodium-glucose transporter 2 and ketone bodies.心力衰竭中骨骼肌异常的治疗方法：钠-葡萄糖共转运体 2 和酮体。
Am J Physiol Heart Circ Physiol. 2022 Feb 1;322(2):H117-H128. doi: 10.1152/ajpheart.00100.2021. Epub 2021 Dec 3.
4
Glucose-Lowering and Metabolic Effects of SGLT2 Inhibitors.SGLT2 抑制剂的降糖和代谢作用。
Heart Fail Clin. 2022 Oct;18(4):529-538. doi: 10.1016/j.hfc.2022.03.004.
5
SGLT2 inhibitors: What role do they play in heart failure with reduced ejection fraction?钠-葡萄糖协同转运蛋白 2 抑制剂：在心衰射血分数降低患者中扮演何种角色？
Nurse Pract. 2021 Jul 1;46(7):30-37. doi: 10.1097/01.NPR.0000753832.85114.65.
6
Metabolism of the failing heart and the impact of SGLT2 inhibitors.衰竭心脏的代谢和 SGLT2 抑制剂的影响。
Expert Opin Drug Metab Toxicol. 2019 Apr;15(4):275-285. doi: 10.1080/17425255.2019.1588886. Epub 2019 Mar 11.
7
Impact of SGLT2 Inhibitors on Serum Sodium in Heart Failure With Reduced Ejection Fraction.钠-葡萄糖协同转运蛋白2抑制剂对射血分数降低的心力衰竭患者血清钠的影响
JACC Heart Fail. 2022 May;10(5):319-320. doi: 10.1016/j.jchf.2022.02.005. Epub 2022 Apr 6.
8
Investigating the place of sodium-glucose cotransporter-2 inhibitors and dual sodium-glucose cotransporter-1 and dual sodium-glucose cotransporter-2 inhibitors in heart failure therapy: a systematic review of the literature.探究钠-葡萄糖协同转运蛋白2抑制剂以及钠-葡萄糖协同转运蛋白1/钠-葡萄糖协同转运蛋白2双重抑制剂在心力衰竭治疗中的地位：文献系统综述
Heart Fail Rev. 2024 Mar;29(2):549-558. doi: 10.1007/s10741-024-10388-9. Epub 2024 Feb 1.
9
SGLT2 Inhibitors: From Antihyperglycemic Agents to All-Around Heart Failure Therapy.钠-葡萄糖协同转运蛋白2抑制剂：从降糖药到全方位心力衰竭治疗药物
Circulation. 2022 Jul 26;146(4):299-302. doi: 10.1161/CIRCULATIONAHA.122.060348. Epub 2022 Jul 25.
10
Focused Updates: SGLT2 Inhibitors in Patients With Heart Failure and/or Chronic Kidney Disease.重点更新：心力衰竭和/或慢性肾脏病患者的 SGLT2 抑制剂。
Ann Pharmacother. 2021 Feb;55(2):252-260. doi: 10.1177/1060028020934001. Epub 2020 Jun 13.

引用本文的文献

1
Multi-omics reveals the mechanism of vagus nerve stimulation in the treatment of chronic congestive heart failure.多组学揭示迷走神经刺激治疗慢性充血性心力衰竭的机制。
Sci Rep. 2025 Jun 4;15(1):19613. doi: 10.1038/s41598-025-04397-3.
2
Influence of sodium-glucose cotransporter 2 inhibitors on the triglyceride-glucose index in acute myocardial infarction patients with type 2 diabetes mellitus.钠-葡萄糖协同转运蛋白2抑制剂对2型糖尿病急性心肌梗死患者甘油三酯-葡萄糖指数的影响
Cardiovasc Diagn Ther. 2024 Dec 31;14(6):1096-1107. doi: 10.21037/cdt-24-287. Epub 2024 Dec 11.
3
SGLT2 inhibition and adipose tissue metabolism: current outlook and perspectives.
钠-葡萄糖协同转运蛋白2抑制与脂肪组织代谢：当前观点与展望
Cardiovasc Diabetol. 2024 Dec 19;23(1):449. doi: 10.1186/s12933-024-02539-x.
4
SGLT2 inhibition improves coronary flow velocity reserve and contractility: role of glucagon signaling.SGLT2 抑制改善冠状动脉血流储备和收缩力：胰高血糖素信号的作用。
Cardiovasc Diabetol. 2024 Nov 15;23(1):408. doi: 10.1186/s12933-024-02491-w.
5
Comparison Between SGLT2 Inhibitors and Lactation: Implications for Cardiometabolic Health in Parous Women.钠-葡萄糖协同转运蛋白2（SGLT2）抑制剂与哺乳期的比较：对经产妇心脏代谢健康的影响
Metab Syndr Relat Disord. 2025 Mar;23(2):77-85. doi: 10.1089/met.2024.0182. Epub 2024 Oct 21.
6
New insights into the cardio-renal benefits of SGLT2 inhibitors and the coordinated role of miR-30 family.钠-葡萄糖协同转运蛋白2抑制剂对心肾的益处及miR-30家族协同作用的新见解。
Genes Dis. 2023 Nov 23;11(6):101174. doi: 10.1016/j.gendis.2023.101174. eCollection 2024 Nov.
7
Effect of henagliflozin on left ventricular mass index in dialysis patients with HFpEF (HELD-HF): protocol for a multicentre, randomised, double-blind, placebo-controlled trial.在 HFpEF（HELD-HF）透析患者中，亨格列净对左心室质量指数的影响：一项多中心、随机、双盲、安慰剂对照试验的方案。
BMJ Open. 2024 Aug 27;14(8):e087617. doi: 10.1136/bmjopen-2024-087617.
8
The Beneficial Effect of the SGLT2 Inhibitor Dapagliflozin in Alleviating Acute Myocardial Infarction-Induced Cardiomyocyte Injury by Increasing the Sirtuin Family SIRT1/SIRT3 and Cascade Signaling.钠-葡萄糖协同转运蛋白 2 抑制剂达格列净通过增加沉默调节蛋白家族 SIRT1/SIRT3 和级联信号减轻急性心肌梗死诱导的心肌细胞损伤的有益作用。
Int J Mol Sci. 2024 Aug 5;25(15):8541. doi: 10.3390/ijms25158541.
9
The Role of Short-Chain Fatty Acids in Myocardial Ischemia-Reperfusion Injury.短链脂肪酸在心肌缺血再灌注损伤中的作用。
Curr Nutr Rep. 2024 Dec;13(4):701-708. doi: 10.1007/s13668-024-00564-6. Epub 2024 Aug 7.
10
Empagliflozin in the treatment of heart failure.恩格列净治疗心力衰竭。
Future Cardiol. 2024 Apr 25;20(5-6):251-261. doi: 10.1080/14796678.2024.2360818. Epub 2024 Jun 12.